Tokyo, Japan

Tomonobu Maruyama


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2006-2008

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Tomonobu Maruyama: Innovator in Flow Cytometry

Introduction

Tomonobu Maruyama is a distinguished inventor based in Tokyo, Japan. He has made significant contributions to the field of flow cytometry, particularly in the classification of leukocytes. His innovative work has led to the development of advanced technologies that enhance the accuracy and efficiency of blood sample analysis.

Latest Patents

Maruyama holds 2 patents, with his latest invention focusing on a flow cytometer designed for classifying leukocytes. This device utilizes a light source that emits a beam in a specific direction, allowing for the detection of scattered light from a blood sample. The first detector measures the intensity of forward small scattered light, while the second detector captures the intensity of forward large scattered light. A processor then classifies the leukocytes based on these detected intensities, significantly improving the detection angle range and overall classification process.

Career Highlights

Throughout his career, Maruyama has been associated with Nihon Kohden Corporation, a leading company in the medical technology sector. His work has not only advanced the field of flow cytometry but has also contributed to the development of innovative medical devices that benefit healthcare professionals and patients alike.

Collaborations

Maruyama has collaborated with notable colleagues, including Yutaka Nagai and Kazuo Yamagishi. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas, further enhancing the impact of their work in the medical technology field.

Conclusion

Tomonobu Maruyama's contributions to flow cytometry exemplify the importance of innovation in medical technology. His patents and collaborative efforts continue to influence the industry, paving the way for future advancements in the classification and analysis of blood samples.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…